(abbreviation, alt-of, countable, ellipsis, informal) Ellipsis of GLP-1 RA (“glucagon-like peptide-1 receptor agonist”), a class of drugs used for the medication of diabetes and weight loss.
Some brides say explicitly that they are using GLP-1s, while for others, Ms. Yang, who said she uses Mounjaro herself, has her suspicions. 2025 April 29, Tammy LaGorce, “How Ozempic Is Shaping Weddings”, in The New York Times, →ISSN:
Those days are gone. WeightWatchers and its commercial diet program peers have struggled to maintain market share in the era of GLP-1s, the class of drugs that includes Ozempic, Wegovy and Mounjaro, which give users a much higher chance of success. 2025 May 15, Jennifer Weiner, “WeightWatchers Got One Thing Very Right”, in The New York Times, →ISSN:
Consumers are also increasingly embracing wellness trends while others are on GLP-1s or medications that curb their desire to snack on sweet or salty foods. 2025 August 25, Julie Creswell, “Krispy Kreme Bets on Big-Box Stores to Stay Fresh”, in The New York Times, New York, N.Y.: The New York Times Company, →ISSN, →OCLC:
If GLP-1 drugs only treated diabetes and did not promote weight loss, they would still be medically groundbreaking. 2023 October 9, Tressie McMillan Cottom, “Ozempic Can’t Fix What Our Culture Has Broken”, in The New York Times, →ISSN:
Its lawyers said it could no longer service a $1.6bn debt load because of an “evolution in consumer preferences and the rapid rise of GLP-1s”, and it was seeking an aggregate valuation of $700mn. 2025 May 10, “WeightWatchers blames diet drugs and social media for Chapter 11 bankruptcy”, in FT Weekend, London: The Financial Times Ltd., →ISSN, →OCLC, page 13:
An apparent conflict between WeightWatchers, which promotes a non-medical, points-based approach to food intake, and the talkshow host came in December when she told People magazine that she integrated GLP-1 drugs, brands that include Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound, into her existing “holistic approach” of “regular exercise and other lifestyle tweaks”. 2024 February 29, Edward Helmore, “Oprah Winfrey announces she is stepping down from WeightWatchers”, in The Guardian, →ISSN: